INTL ZEOLITE
International Zeolite Corp. engages in the exploration and development of mineral properties in Canada. It operates through two segments, Exploration and Development, and Retail and Commercial Sales. The company hold interests in the Bromley Creek zeolite project that covers an area of approximately 640.21 hectares located near Princeton, British Columbia; and the Sun Group zeolite property, cons… Read more
INTL ZEOLITE (ZEON) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INTL ZEOLITE (ZEON) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INTL ZEOLITE - Net Assets Trend (None–None)
This chart illustrates how INTL ZEOLITE's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INTL ZEOLITE (None–None)
The table below shows the annual net assets of INTL ZEOLITE from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INTL ZEOLITE's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INTL ZEOLITE Competitors by Market Cap
The table below lists competitors of INTL ZEOLITE ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CYBERAGENT (CL2.SG)
STU:CL2
|
$70.33K |
|
Canadian Banc Corp
PINK:CNDCF
|
$70.36K |
|
DCI O.N.
F:DCIK
|
$70.45K |
|
VTECH HLDGS
MU:VTCB
|
$70.47K |
|
Argentum Silver Corp
PINK:AGSVF
|
$70.25K |
|
Kyntra Bio, Inc.
NASDAQ:KYNB
|
$70.25K |
|
RENT3F
SA:RENT3F
|
$70.24K |
|
BIOCRYST PHARM
MU:BO1
|
$70.21K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INTL ZEOLITE's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INTL ZEOLITE's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INTL ZEOLITE utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INTL ZEOLITE's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $18,803,803,535
- Average return on equity (ROE) among peers: -24.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INTL ZEOLITE (ZEON) | €- | N/A | N/A | $70.30K |
| Kureha Corporation (0K1) | $162.17 Billion | 8.59% | 0.53x | $845.56 Million |
| Polwax S.A (1LW) | $54.23 Million | -71.97% | 1.06x | $3.33 Million |
| H&R GmbH & Co. KGaA (2HRA) | $287.13 Million | 9.37% | 1.19x | $34.48 Million |
| Renaissance Oil Corp (2R7) | $2.68 Billion | 6.64% | 1.08x | $1.31 Billion |
| Global New Material International Holdings Limited (69Y) | $4.35 Billion | 5.56% | 0.62x | $625.83 Million |
| Altech Chemicals Ltd (A3Y) | $33.88 Million | -176.29% | 0.32x | $18.88 Million |
| Beijing Media Corporation Limited (BME) | $1.20 Billion | -7.10% | 0.16x | $1.77 Million |
| BRAIN Biotech AG (BNN) | $17.59 Million | -23.28% | 0.43x | $40.42 Million |
| Brenntag SE (BNR) | $2.69 Billion | 13.57% | 1.59x | $5.87 Billion |
| Huabao International Holdings Limited (CEY) | $14.56 Billion | -7.24% | 0.14x | $1.44 Billion |